Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Ho

Showing results (71-80 of 253) with videos related to

Pageof 26
Sort By:
Journal of the American Heart Association|October 27, 2023
Circulating Cardiovascular Biomarkers in Cancer Therapeutics-Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future DirectionsGillian Murtagh, James L Januzzi, Marielle Scherrer-Crosbie, et al.
JACC. Heart Failure|June 15, 2020
Impaired Exercise Tolerance in Heart Failure With Preserved Ejection Fraction: Quantification of Multiorgan System Reserve CapacityMatthew Nayor, Nicholas E Houstis, Mayooran Namasivayam, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Association of Obesity with Kidney Function Outcomes in Heart Failure with Preserved Ejection FractionLixia Deng, Hocine Tighiouart, Tatsufumi Oka, et al.
European Journal of Heart Failure|February 26, 2013
Association of physical activity and heart failure with preserved vs. reduced ejection fraction in the elderly: the Framingham Heart StudyElisabeth Kraigher-Krainer, Asya Lyass, Joseph M Massaro, et al.
JAMA Cardiology|March 4, 2023
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection FractionLaura P Cohen, Nicolas Isaza, Inmaculada Hernandez, et al.
Kidney360|April 1, 2026
Association of Obesity with Kidney Function Outcomes in Heart Failure with Preserved Ejection FractionLixia Deng, Hocine Tighiouart, Tatsufumi Oka, et al.
Circulation. Heart Failure|December 8, 2022
The Association of Protein Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection FractionKatherine S Takvorian, Dongyu Wang, Paul Courchesne, et al.
Journal of the American College of Cardiology|December 11, 2012
Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetesDavid D Waters, Jennifer E Ho, S Matthijs Boekholdt, et al.
AIDS (London, England)|March 3, 2012
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV diseaseJennifer E Ho, Rebecca Scherzer, Frederick M Hecht, et al.
JACC. Basic to Translational Science|February 3, 2021
Galectin-3 Inhibition With Modified Citrus Pectin in HypertensionEmily S Lau, Elizabeth Liu, Samantha M Paniagua, et al.
Pageof 26

Showing results (71-80 of 253) with videos related to

Sort By:
Pageof 26
Journal of the American Heart Association|October 27, 2023
Circulating Cardiovascular Biomarkers in Cancer Therapeutics-Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future DirectionsGillian Murtagh, James L Januzzi, Marielle Scherrer-Crosbie, et al.
JACC. Heart Failure|June 15, 2020
Impaired Exercise Tolerance in Heart Failure With Preserved Ejection Fraction: Quantification of Multiorgan System Reserve CapacityMatthew Nayor, Nicholas E Houstis, Mayooran Namasivayam, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Association of Obesity with Kidney Function Outcomes in Heart Failure with Preserved Ejection FractionLixia Deng, Hocine Tighiouart, Tatsufumi Oka, et al.
European Journal of Heart Failure|February 26, 2013
Association of physical activity and heart failure with preserved vs. reduced ejection fraction in the elderly: the Framingham Heart StudyElisabeth Kraigher-Krainer, Asya Lyass, Joseph M Massaro, et al.
JAMA Cardiology|March 4, 2023
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection FractionLaura P Cohen, Nicolas Isaza, Inmaculada Hernandez, et al.
Kidney360|April 1, 2026
Association of Obesity with Kidney Function Outcomes in Heart Failure with Preserved Ejection FractionLixia Deng, Hocine Tighiouart, Tatsufumi Oka, et al.
Circulation. Heart Failure|December 8, 2022
The Association of Protein Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection FractionKatherine S Takvorian, Dongyu Wang, Paul Courchesne, et al.
Journal of the American College of Cardiology|December 11, 2012
Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetesDavid D Waters, Jennifer E Ho, S Matthijs Boekholdt, et al.
AIDS (London, England)|March 3, 2012
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV diseaseJennifer E Ho, Rebecca Scherzer, Frederick M Hecht, et al.
JACC. Basic to Translational Science|February 3, 2021
Galectin-3 Inhibition With Modified Citrus Pectin in HypertensionEmily S Lau, Elizabeth Liu, Samantha M Paniagua, et al.
Pageof 26